SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w
KAWASAKI,Japan,Feb. 13,2025-- Fujitsu today announced the launch of theFujitsu Cloud Service Generative AI Platform. The new service,which combines data confidentiality with the ease of use of the clo
Overnight trading of all S&P 500®,Nasdaq-100® stocks and hundreds of ETFs is now available to all Schwab clients via the thinkorswim® platform suite
XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).
JAKARTA,Indonesia,Feb. 13,2025-- PT Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) continues to demonstrate resilience amid economic challenges,recording a consolidated net profit of IDR 60.64 trilli
PUNE,India,Feb. 13,2025-- enreapis proud to be Certified™ by Great Place To Work® for the third year in a row. The prestigious award is based entirely on what current employees say about their ex
